       Document 0347
 DOCN  M9620347
 TI    [HTLV-II infection in Spain. Analysis of 113 cases identified until
       November, 1994. Spanish Group for the Study of HTLV/I/II]
 DT    9602
 AU    Soriano V; Gutierrez M; Vallejo A; Tuset C; Dronda F; Pujol E; Instituto
       de Salud Carlos III, Madrid.
 SO    Med Clin (Barc). 1995 Sep 9;105(7):251-4. Unique Identifier : AIDSLINE
       MED/96059193
 AB    BACKGROUND: HTLV-II is a human retrovirus considered to be responsible
       for the genesis of some lymphoproliferative and neurologic syndromes.
       The virus is endemic in some Amerindian and African tribes as well
       amongst injecting drug addicts (IDA) in North America and Europe.
       METHODS: The clinical, epidemiologic and virologic characteristics of
       the patients with HTLV-II infection identified in Spain up to November
       1994 are described. RESULTS: One hundred thirteen subjects have been
       identified with HTLV-II infection in Spain with 4 being African
       immigrants residing in Madrid and the remaining being IDA from other
       European countries. Most were males (94/113; 83%). All were IDA except
       six (5 had acquired the infection by sexual contact and one by blood
       transfusion). Most of the IDA infected with HTLV-II were coinfected with
       HIV-1 (93/113; 83%). No patient showed clinical manifestations
       attributable to HTLV-II infection although one drug addict male
       coinfected with HIV-1 and HTLV-II developed a non-inflammatory proximal
       myopathy. CONCLUSIONS: Infection by HTLV-II is present in Spain and
       affects with preference to injecting drug addicts. It has been shown to
       be of growing incidence with a current global prevalence of 2% in IDA.
 DE    Adult  English Abstract  Female  Human  HTLV-II Infections/*EPIDEMIOLOGY
       Male  Spain/EPIDEMIOLOGY  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

